Toxicity following high-dose three-dimensional conformal and intensity-modulated radiation therapy for clinically localized prostate cancer.

[1]  J Kurhanewicz,et al.  Sextant localization of prostate cancer: comparison of sextant biopsy, magnetic resonance imaging and magnetic resonance spectroscopic imaging with step section histology. , 2000, The Journal of urology.

[2]  A. Markoe,et al.  Preliminary report of toxicity following 3D radiation therapy for prostate cancer on 3DOG/RTOG 9406. , 2000, International journal of radiation oncology, biology, physics.

[3]  P. Carroll,et al.  Prostate cancer: localization with three-dimensional proton MR spectroscopic imaging--clinicopathologic study. , 1999, Radiology.

[4]  L Verhey,et al.  Static field intensity modulation to treat a dominant intra-prostatic lesion to 90 Gy compared to seven field 3-dimensional radiotherapy. , 1999, International journal of radiation oncology, biology, physics.

[5]  E. Feuer,et al.  Cancer surveillance series: interpreting trends in prostate cancer--part I: Evidence of the effects of screening in recent prostate cancer incidence, mortality, and survival rates. , 1999, Journal of the National Cancer Institute.

[6]  M. Zelefsky,et al.  Long term tolerance of high dose three‐dimensional conformal radiotherapy in patients with localized prostate carcinoma , 1999, Cancer.

[7]  T E Schultheiss,et al.  Survival advantage for prostate cancer patients treated with high-dose three-dimensional conformal radiotherapy. , 1999, The cancer journal from Scientific American.

[8]  D. Dearnaley,et al.  Comparison of radiation side-effects of conformal and conventional radiotherapy in prostate cancer: a randomised trial , 1999, The Lancet.

[9]  William R. Fair,et al.  DOSE ESCALATION WITH THREE-DIMENSIONAL CONFORMAL RADIATION THERAPY AFFECTS THE OUTCOME IN PROSTATE CANCER , 1998 .

[10]  A. Pollack,et al.  Late effects after radiotherapy for prostate cancer in a randomized dose-response study: results of a self-assessment questionnaire. , 1998, Urology.

[11]  T E Schultheiss,et al.  Dose escalation with 3D conformal treatment: five year outcomes, treatment optimization, and future directions. , 1998, International journal of radiation oncology, biology, physics.

[12]  P. Xia,et al.  Comparison of intensity modulated treatment plans for multiple dominant intra-prostatic lesions of prostate cancer , 1998 .

[13]  M. Roach,et al.  Improved freedom from PSA failure with whole pelvic irradiation for high-risk prostate cancer. , 1998, International journal of radiation oncology, biology, physics.

[14]  Taylor Murray,et al.  Cancer statistics, 1998 , 1998, CA: a cancer journal for clinicians.

[15]  A. Pollack,et al.  External beam radiotherapy dose response of prostate cancer. , 1997, International journal of radiation oncology, biology, physics.

[16]  H. Sandler,et al.  Results of 3D conformal radiotherapy in the treatment of localized prostate cancer. , 1997, International journal of radiation oncology, biology, physics.

[17]  A. Hanlon,et al.  Rectal bleeding after conformal 3D treatment of prostate cancer: time to occurrence, response to treatment and duration of morbidity. , 1997, International journal of radiation oncology, biology, physics.

[18]  A. Hanlon,et al.  Chronic rectal bleeding after high-dose conformal treatment of prostate cancer warrants modification of existing morbidity scales. , 1997, International journal of radiation oncology, biology, physics.

[19]  M. Roach,et al.  Radiotherapy for high grade clinically localized adenocarcinoma of the prostate. , 1996, The Journal of urology.

[20]  L. Verhey,et al.  The "critical volume tolerance method" for estimating the limits of dose escalation during three-dimensional conformal radiotherapy for prostate cancer. , 1996, International journal of radiation oncology, biology, physics.

[21]  P. Carroll,et al.  Three-dimensional H-1 MR spectroscopic imaging of the in situ human prostate with high (0.24-0.7-cm3) spatial resolution. , 1996, Radiology.

[22]  H. Sandler,et al.  Three dimensional conformal radiotherapy for the treatment of prostate cancer: low risk of chronic rectal morbidity observed in a large series of patients. , 1995, International journal of radiation oncology, biology, physics.

[23]  L. Verhey,et al.  The value of nonuniform margins for six-field conformal irradiation of localized prostate cancer. , 1995, International journal of radiation oncology, biology, physics.

[24]  B Pickett,et al.  Optimization of the oblique angles in the treatment of prostate cancer during six-field conformal radiotherapy. , 1994, Medical dosimetry : official journal of the American Association of Medical Dosimetrists.

[25]  P. Rubin,et al.  Long-term treatment sequelae following external beam irradiation for adenocarcinoma of the prostate: analysis of RTOG studies 7506 and 7706. , 1991, International journal of radiation oncology, biology, physics.

[26]  G E Hanks,et al.  The effect of dose on local control of prostate cancer. , 1988, International journal of radiation oncology, biology, physics.

[27]  S. Leibel,et al.  Patterns of care outcome studies: results of the national practice in adenocarcinoma of the prostate. , 1984, International journal of radiation oncology, biology, physics.